Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial
1. Tasimelteon significantly reduced sleep onset latency from the first night, with improvements maintained over 4 weeks in patients with ...
